Semi-Annual Statement Of Income And Retained Earnings

Fuji Pharma Co.,Ltd. - Filing #7290798

Concept 2023-10-01 to
2024-09-30
2023-10-01 to
2024-09-30
2023-10-01 to
2024-09-30
2023-10-01 to
2024-09-30
2023-10-01 to
2024-09-30
2023-10-01 to
2024-09-30
2023-10-01 to
2024-09-30
2022-10-01 to
2023-09-30
2022-10-01 to
2023-09-30
2022-10-01 to
2023-09-30
2022-10-01 to
2023-09-30
2022-10-01 to
2023-09-30
2022-10-01 to
2023-09-30
2022-10-01 to
2023-09-30
Semi-annual statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
3,430,000,000 JPY
3,880,000,000 JPY
3,458,000,000 JPY
3,858,000,000 JPY
Non-operating income
Non-operating income
761,000,000 JPY
812,000,000 JPY
732,000,000 JPY
790,000,000 JPY
Non-operating expenses
Non-operating expenses
238,000,000 JPY
247,000,000 JPY
119,000,000 JPY
129,000,000 JPY
Ordinary profit (loss)
3,953,000,000 JPY
4,445,000,000 JPY
4,071,000,000 JPY
4,519,000,000 JPY
Extraordinary income
Extraordinary income
3,953,000,000 JPY
3,953,000,000 JPY
JPY
JPY
Extraordinary losses
Extraordinary losses
123,000,000 JPY
123,000,000 JPY
120,000,000 JPY
120,000,000 JPY
Profit (loss) before income taxes
7,784,000,000 JPY
8,276,000,000 JPY
3,951,000,000 JPY
4,399,000,000 JPY
Income taxes - current
1,908,000,000 JPY
2,110,000,000 JPY
871,000,000 JPY
1,002,000,000 JPY
Income taxes - deferred
66,000,000 JPY
18,000,000 JPY
-37,000,000 JPY
-38,000,000 JPY
Profit (loss)
5,808,000,000 JPY
6,147,000,000 JPY
5,808,000,000 JPY
5,808,000,000 JPY
5,808,000,000 JPY
JPY
JPY
JPY
3,117,000,000 JPY
3,117,000,000 JPY
3,117,000,000 JPY
3,435,000,000 JPY
3,117,000,000 JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.